New hope for chronic stomach discomfort? Real-World study tests common medication
NCT ID NCT07165301
Summary
This study follows 200 patients with functional dyspepsia (chronic stomach discomfort without clear cause) who are prescribed itopride as part of their normal medical care. Researchers will track how well the medication relieves symptoms like bloating, pain, and fullness over 16 weeks, while also measuring impacts on daily life and work productivity. This is an observational study, meaning patients receive standard treatment while researchers collect real-world data on effectiveness.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FUNCTIONAL DYSPEPSIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UZ Leuven
Leuven, 3000, Belgium
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.